GlassScriptPhysician profile
Julie Waight
NPI 1871594788
$4,939.09
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,520 · 2022: $1,396 · 2023: $1,330 · 2024: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,022.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,453.18 | 2021-2024 | |
| Amgen INC. | $699.24 | 2021-2024 | Aimovig |
| Teva Pharmaceuticals USA, INC. | $517.55 | 2021-2024 | Ajovy |
| Pfizer INC. | $391.94 | 2023-2024 | |
| Impel Pharmaceuticals INC. | $340.40 | 2022-2023 | Trudhesa |
| Biohaven Pharmaceutical Holding Company LTD. | $316.82 | 2022 | |
| Amneal Pharmaceuticals LLC | $273.18 | 2021-2023 | Lyvispah |
| Novartis Pharmaceuticals Corporation | $149.78 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.61 | 2021-2023 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $113.99 | 2021 | |
| Avanir Pharmaceuticals, INC. | $104.06 | 2021-2022 | |
| Lundbeck LLC | $78.73 | 2021-2023 | Vyepti |
| Upsher-Smith Laboratories LLC | $76.88 | 2022-2023 | |
| Scilex Pharmaceuticals INC. | $63.51 | 2022-2023 | Ztlido |
| Sk Life Science, INC. | $55.92 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $43.34 | 2021-2022 | |
| Lilly USA, LLC | $38.39 | 2021 | |
| Arbor Pharmaceuticals, INC. | $33.39 | 2021 | |
| Azurity Pharmaceuticals, INC. | $32.99 | 2023 | Horizant |
| Allergan, INC. | $18.11 | 2021 | |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Waight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.